SPEED ROUND: CATCH UP QUICK

Rameda acquires new molecule, Dana gas isn’t complaining

EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn’t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with “an established market presence.” The company said the acquisition will be its largest…